New Brunswick, MD, United States of America

Leonid Minakhin

This inventor holds 2 USPTO granted patents. Top assignees: Harvard College, Massachusetts Institute of Technology, Rutgers, The State University of New Jersey. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leonid Minakhin. Retrieved from https://idiyas.com/inventor/leonid-minakhin-dngkl90j

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 12.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Leonid Minakhin: Innovator in CRISPR Technology

Introduction

Leonid Minakhin is a prominent inventor known for his contributions to the field of genetic engineering, particularly in the development of CRISPR enzymes and systems. His innovative work has paved the way for advancements in targeting nucleic acids, which has significant implications for biotechnology and medicine.

Latest Patents

Minakhin holds a patent for CRISPR enzymes and systems. This invention provides systems, methods, and compositions for targeting nucleic acids. In particular, it offers non-naturally occurring or engineered DNA or RNA-targeting systems that comprise a novel DNA or RNA-targeting CRISPR effector protein and at least one targeting nucleic acid component, such as a guide RNA. He has 1 patent to his name.

Career Highlights

Throughout his career, Minakhin has worked with prestigious institutions, including the Broad Institute, Inc. and the Massachusetts Institute of Technology. His research has significantly contributed to the understanding and application of CRISPR technology in various scientific fields.

Collaborations

Minakhin has collaborated with notable scientists, including Eugene Koonin and Feng Zhang, who are also recognized for their work in the field of CRISPR and genetic research.

Conclusion

Leonid Minakhin's innovative contributions to CRISPR technology have established him as a key figure in genetic engineering. His work continues to influence advancements in biotechnology and medicine.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…